Industry: Medical Testing
Digene develops, manufactures and markets proprietary DNA and RNA testing systems for the screening, monitoring and diagnosis of women’s infectious diseases and cancer. Innovator of Hybrid Capture® 2 (hc2) technology, Digene provides laboratory customers with molecular diagnostics products designed for clinical accuracy and laboratory efficiency. Digene’s proprietary Hybrid Capture® platform provides accurate, cost,effective, user,friendly signal amplification of DNA that is ideally suited to the diagnosis and management of infectious disease. Digene’s product portfolio includes flagship product The Digene® HPV Test*, DNA tests for the detection of other sexually transmitted infections including chlamydia (CT) and gonorrhea (GC), and tests for blood ( www.digene.com )
Digene Corporation
1201 Clopper Road
Gaithersburg, Maryland 20878
USA
Tel: (301) 944-7000
Fax: (240) 632-7121